Short Interest in Concord Medical Services Holdings Limited (NYSE:CCM) Drops By 60.1%

Posted by Patrick Bannon on Jul 27th, 2026

Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) saw a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 2,980 shares, a decrease of 60.1% from the June 30th total of 7,461 shares. Based on an average daily volume of 77,063 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.1% of the company’s shares are short sold.

Concord Medical Services Stock Performance

NYSE CCM opened at $4.24 on Monday. The business has a 50 day simple moving average of $4.69 and a 200 day simple moving average of $4.27. Concord Medical Services has a one year low of $3.18 and a one year high of $6.98. The company has a quick ratio of 0.46, a current ratio of 0.48 and a debt-to-equity ratio of 1.33.

Concord Medical Services (NYSE:CCM – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

View Our Latest Analysis on Concord Medical Services

About Concord Medical Services

(Get Free Report)

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.